197 related articles for article (PubMed ID: 7318982)
41. In vivo studies on hemopoietic stem cells and target cells for Friend virus infection in vitro.
Seidel HJ; Kreja L
Exp Hematol; 1982 May; 10(5):459-66. PubMed ID: 7095020
[TBL] [Abstract][Full Text] [Related]
42. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of monolayer, liquid, gelfoam sponge and artificial capillary culture systems for the study of hematopoiesis.
Anderson RW; Sharp JG
Exp Hematol; 1981 Feb; 9(2):187-96. PubMed ID: 7238650
[TBL] [Abstract][Full Text] [Related]
44. A preliminary report: preparations containing Interleukin-3 (IL-3) promote proliferation of multipotential stem cells (CFUs) in the mouse.
Garland JM; Crompton S
Exp Hematol; 1983 Sep; 11(8):757-61. PubMed ID: 6414839
[TBL] [Abstract][Full Text] [Related]
45. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
[TBL] [Abstract][Full Text] [Related]
46. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
47. Serum-free culture conditions for cells capable of producing long-term survival in lethally irradiated mice.
Brown RL; Xu FS; Dusing SK; Li Q; Fischer R; Patchen M
Stem Cells; 1997; 15(3):237-45. PubMed ID: 9170216
[TBL] [Abstract][Full Text] [Related]
48. Protection of normal hematopoietic stem cells from the toxicity of purine base analogs: in vivo application.
Epstein J; Preisler HD
Cancer Treat Rep; 1984 Sep; 68(9):1153-6. PubMed ID: 6206944
[TBL] [Abstract][Full Text] [Related]
49. Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells.
Eto T; Winkler I; Purton LE; Lévesque JP
Exp Hematol; 2005 Feb; 33(2):232-42. PubMed ID: 15676218
[TBL] [Abstract][Full Text] [Related]
50. Effect of adenine nucleotides on granulopoiesis and lithium-induced granulocytosis in long-term bone marrow cultures.
Gualtieri RJ; Berne RM; McGrath HE; Huster WJ; Quesenberry PJ
Exp Hematol; 1986 Aug; 14(7):689-95. PubMed ID: 3015647
[TBL] [Abstract][Full Text] [Related]
51. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
Van Overstraeten-Schlögel N; Beguin Y; Gothot A
Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
[TBL] [Abstract][Full Text] [Related]
52. Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta.
Waegell WO; Higley HR; Kincade PW; Dasch JR
Exp Hematol; 1994 Oct; 22(11):1051-7. PubMed ID: 7925771
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of hemopoietic stem cell proliferation by prostaglandin inhibitory drugs.
Estrov Z; Resnitzky P
Exp Hematol; 1983 Oct; 11(9):802-9. PubMed ID: 6139289
[TBL] [Abstract][Full Text] [Related]
54. In vivo stimulatory effect of macrophage colony-stimulating factor on the number of stroma-initiating cells.
Tanaka-Douzono M; Suzu S; Yamada M; Misawa E; Wakimoto N; Shimamura S; Hatake K; Motoyoshi K
J Cell Physiol; 1999 Feb; 178(2):267-73. PubMed ID: 10048591
[TBL] [Abstract][Full Text] [Related]
55. The effect of prostaglandin E1 on hemopoiesis in long-term bone marrow cultures.
Motomura S; Dexter TM
Exp Hematol; 1980 Mar; 8(3):298-303. PubMed ID: 6970134
[TBL] [Abstract][Full Text] [Related]
56. Influence of IL-10 on murine CFU-pre-B formation.
Fine JS; Macosko HD; Grace MJ; Narula SK
Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782
[TBL] [Abstract][Full Text] [Related]
57. Conditions that support long-term production of osteoclast progenitors in vitro.
Lee MY; Fevold KL; Muguruma Y; Lottsfeldt JL
Stem Cells; 1997; 15(5):340-6. PubMed ID: 9323795
[TBL] [Abstract][Full Text] [Related]
58. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
59. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system.
Lill MC; Lynch M; Fraser JK; Chung GY; Schiller G; Glaspy JA; Souza L; Baldwin GC; Gasson JC
Stem Cells; 1994 Nov; 12(6):626-37. PubMed ID: 7533581
[TBL] [Abstract][Full Text] [Related]
60. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
